4D Molecular Therapeutics, Inc. — DEF 14A Filings
5 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by 4D Molecular Therapeutics, Inc. (FDMT), sorted by most recent first. Each row links to the full filing on EdgarLookup. 4D Molecular Therapeutics, Inc. has filed 5 DEF 14A documents with the SEC since 2015. To view all SEC filings by 4D Molecular Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001140361-25-016307 | Apr 29, 2025 | Jun 17, 2025 |
| DEF 14A | DEF 14A | 0001140361-24-019090 | Apr 10, 2024 | May 21, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-098511 | Apr 12, 2023 | May 23, 2023 |
| DEF 14A | DEF 14A | 0001193125-22-104263 | Apr 13, 2022 | May 23, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-107762 | Apr 6, 2021 | May 17, 2021 |